FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315433265> ?p ?o ?g. }

• W4315433265 abstract "Based on the suppressor of cytokine signaling 1 (SOCS1)/Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) pathway, the mechanism of oxymatrine in the treatment of atopic dermatitis (AD) was preliminarily explored in this study. C57BL/6 mice were induced to establish AD model by smearing carbotriol (MC903) on their back. The AD mice were randomly divided into model group, oxymatrine groups with three dosages (25, 50 and 100 mg/kg), (n = 10). Oxymatrine groups were intragastric administered once daily for 14 days. The same volume of saline was given in the normal control group and model group once daily for 14 days. Subsequently, HE staining was used to observe the pathological changes of skin tissue, ELISA was used to detect the levels of serum inflammatory factors including interleukin-4, 6 and 17 (IL-4, IL-6, and IL-17), tumor necrosis factor-α (TNF-α) and immunoglobulin E (IgE). Immunohistochemistry was used to detect the expression of suppressor of cytokine signaling 1 and CD3 in skin tissue, and Western blotting was used to detect the proteins in suppressor of cytokine signaling 1/JAK-STAT3 pathway. Compared with the normal control group, the pathological damage of mice in the model group, such as skin hyperplasia, edema, congestion and inflammatory infiltration, aggravated increased significantly. And the expression of serum inflammatory factors, CD3 positive expression and JAK-STAT3 pathway protein in the model group were increased (p < .05), and the expression of suppressor of cytokine signaling 1 protein (p < .05) was decreased. Compared with the model group, the above pathological damage of the mice was reduced, and the serum inflammatory factors, JAK-STAT3 pathway protein, and CD3 positive expression were decreased as a dose-dependant manner (p < .05), and the expression of suppressor of cytokine signaling 1 protein was increased as a dose-dependent manner (p < .05). Oxymatrine can improve the skin inflammation symptoms of AD mice by up regulating the expression of suppressor of cytokine signaling 1, inhibiting the activation of JAK-STAT3 pathway and blocking the activation of T lymphocytes." @default.
• W4315433265 created "2023-01-11" @default.
• W4315433265 creator A5018113884 @default.
• W4315433265 creator A5019560977 @default.
• W4315433265 creator A5022164362 @default.
• W4315433265 creator A5030863883 @default.
• W4315433265 creator A5068906700 @default.
• W4315433265 creator A5070370013 @default.
• W4315433265 creator A5087413046 @default.
• W4315433265 date "2023-01-10" @default.
• W4315433265 modified "2023-09-27" @default.
• W4315433265 title "The mechanism of oxymatrine on atopic dermatitis in mice based on SOCS1/JAK-STAT3 pathway" @default.
• W4315433265 cites W1560549396 @default.
• W4315433265 cites W2765896170 @default.
• W4315433265 cites W2806413187 @default.
• W4315433265 cites W2809796857 @default.
• W4315433265 cites W2920206917 @default.
• W4315433265 cites W2953851569 @default.
• W4315433265 cites W2968659435 @default.
• W4315433265 cites W2972228782 @default.
• W4315433265 cites W2978121472 @default.
• W4315433265 cites W2985186598 @default.
• W4315433265 cites W3008145146 @default.
• W4315433265 cites W3030435859 @default.
• W4315433265 cites W3081573253 @default.
• W4315433265 cites W3093018651 @default.
• W4315433265 cites W3164790136 @default.
• W4315433265 cites W3197939681 @default.
• W4315433265 cites W3199738914 @default.
• W4315433265 doi "https://doi.org/10.3389/fphar.2022.1091090" @default.
• W4315433265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36703757" @default.
• W4315433265 hasPublicationYear "2023" @default.
• W4315433265 type Work @default.
• W4315433265 citedByCount "2" @default.
• W4315433265 countsByYear W43154332652023 @default.
• W4315433265 crossrefType "journal-article" @default.
• W4315433265 hasAuthorship W4315433265A5018113884 @default.
• W4315433265 hasAuthorship W4315433265A5019560977 @default.
• W4315433265 hasAuthorship W4315433265A5022164362 @default.
• W4315433265 hasAuthorship W4315433265A5030863883 @default.
• W4315433265 hasAuthorship W4315433265A5068906700 @default.
• W4315433265 hasAuthorship W4315433265A5070370013 @default.
• W4315433265 hasAuthorship W4315433265A5087413046 @default.
• W4315433265 hasBestOaLocation W43154332651 @default.
• W4315433265 hasConcept C112392421 @default.
• W4315433265 hasConcept C11988809 @default.
• W4315433265 hasConcept C121608353 @default.
• W4315433265 hasConcept C126042315 @default.
• W4315433265 hasConcept C126322002 @default.
• W4315433265 hasConcept C14077384 @default.
• W4315433265 hasConcept C157333092 @default.
• W4315433265 hasConcept C170493617 @default.
• W4315433265 hasConcept C171958077 @default.
• W4315433265 hasConcept C179185449 @default.
• W4315433265 hasConcept C17991360 @default.
• W4315433265 hasConcept C203014093 @default.
• W4315433265 hasConcept C2776245682 @default.
• W4315433265 hasConcept C2778690821 @default.
• W4315433265 hasConcept C2778923194 @default.
• W4315433265 hasConcept C42362537 @default.
• W4315433265 hasConcept C62478195 @default.
• W4315433265 hasConcept C71924100 @default.
• W4315433265 hasConcept C86803240 @default.
• W4315433265 hasConcept C95444343 @default.
• W4315433265 hasConcept C98274493 @default.
• W4315433265 hasConceptScore W4315433265C112392421 @default.
• W4315433265 hasConceptScore W4315433265C11988809 @default.
• W4315433265 hasConceptScore W4315433265C121608353 @default.
• W4315433265 hasConceptScore W4315433265C126042315 @default.
• W4315433265 hasConceptScore W4315433265C126322002 @default.
• W4315433265 hasConceptScore W4315433265C14077384 @default.
• W4315433265 hasConceptScore W4315433265C157333092 @default.
• W4315433265 hasConceptScore W4315433265C170493617 @default.
• W4315433265 hasConceptScore W4315433265C171958077 @default.
• W4315433265 hasConceptScore W4315433265C179185449 @default.
• W4315433265 hasConceptScore W4315433265C17991360 @default.
• W4315433265 hasConceptScore W4315433265C203014093 @default.
• W4315433265 hasConceptScore W4315433265C2776245682 @default.
• W4315433265 hasConceptScore W4315433265C2778690821 @default.
• W4315433265 hasConceptScore W4315433265C2778923194 @default.
• W4315433265 hasConceptScore W4315433265C42362537 @default.
• W4315433265 hasConceptScore W4315433265C62478195 @default.
• W4315433265 hasConceptScore W4315433265C71924100 @default.
• W4315433265 hasConceptScore W4315433265C86803240 @default.
• W4315433265 hasConceptScore W4315433265C95444343 @default.
• W4315433265 hasConceptScore W4315433265C98274493 @default.
• W4315433265 hasLocation W43154332651 @default.
• W4315433265 hasLocation W43154332652 @default.
• W4315433265 hasLocation W43154332653 @default.
• W4315433265 hasOpenAccess W4315433265 @default.
• W4315433265 hasPrimaryLocation W43154332651 @default.
• W4315433265 hasRelatedWork W1600880434 @default.
• W4315433265 hasRelatedWork W2007199665 @default.
• W4315433265 hasRelatedWork W2009085380 @default.
• W4315433265 hasRelatedWork W2372981780 @default.
• W4315433265 hasRelatedWork W2886232209 @default.
• W4315433265 hasRelatedWork W2887441368 @default.
• W4315433265 hasRelatedWork W4235224349 @default.
• W4315433265 hasRelatedWork W4247320009 @default.
• W4315433265 hasRelatedWork W4315433265 @default.

• next